Esperite N.V. (ESP) with CryoSave contributes to treating a 9 year old child with Thalassemia Major in Switzerland

April 25, 2017 Group News
shutterstock_75799198

CryoSave confirms the importance of cord blood stem cells in regenerative medicine.

Last week, CryoSave released a cord blood stem cell unit from the state of the art laboratory in Geneva for the clinical treatment of a young boy who suffers from thalassemia major. The 9 year old patient will receive an allogeneic transplant in Switzerland of the cord blood stem cells from his now 2 year old brother.

Zutphen, The Netherlands – 25 April 2017

read more

ESPERITE pioneers first treatment worldwide of Cerebral Palsy using two types of stem cells

February 23, 2015 Group News
shutterstock_75799198

ESPERITE pioneers first treatment worldwide of Cerebral Palsy using two types of stem cells

CryoSave, part of ESPERITE, is the only private cord blood bank sponsoring a GCP clinical trial according to GMP-ATMP international guidelines

CryoSave leads and sponsors a multicentre clinical trial following GCP-ICH standards, for investigation of new treatment of Cerebral Palsy using dual infusion of two types of stem cells derived from umbilical cord blood and cord tissue processed by CryoSave

Geneva, Switzerland – 23 February 2015

read more

ESPERITE’S R&D division “The Cell Factory” implements GMP stem cell bioproduction technology and aims the cerebral palsy as first clinical trial

September 25, 2014 Group News
blog_img2

Esperite (Euronext.: ESP), the European leader in stem cells cryopreservation now entering the fields of predictive medicine and translational regenerative medicine R&D, implements its own proprietary new technology for clinical grade production of autologous mesenchymal and stromal stem cells in its business unit The Cell Factory.

Zutphen, The Netherlands – 25 September 2014

read more

Child with cerebral palsy treated with umbilical cord blood derived autologous stem cells

December 12, 2013 Group News

Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, or ‘the Group’), the leading international stem cell storage company and the largest family stem cell bank in Europe announces that on December 10th 2013 a 4-year-old girl in Spain received an infusion of stem cells derived from her own umbilical cord blood for the treatment of her cerebral palsy. Cerebral palsy is one of the main areas of investigation of umbilical cord blood stem cell therapies.

read more

In the year of the 25th anniversary of the first umbilical cord blood transplant Cryo-Save reaches 250,000 stored stem cell samples

October 7, 2013 Group News

Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, or ‘the Group’), the leading international stem cell storage company and the largest family stem cell bank in Europe, announces that it reached the major milestone of storing more than 250,000 stem cell samples since its foundation in 2000. At the same time, October 2013 marks the 25th anniversary of the first umbilical cord blood transplant performed by Dr. Eliane Gluckman in October 1988.

read more

New freezing procedure increases availability of cord blood stem cell transplants for patients

February 7, 2013 Group News

A large enough number of stem cells are needed to ensure the success of a cord blood transplant. However, the quantity of stem cells isolated from umbilical cord blood is not always sufficient to meet that requirement. Researchers from the Etablissement Français du Sang, Aquitaine-Limousin (France) have established a method to multiply cord blood stem cells to required quantity levels. In the current study Dr. Ivanovic and co-workers (Etablissement Français du Sang Aquitaine-Limousin) and a team of Cryo-Save researchers have demonstrated that these cultured stem cells can be frozen and thawed without negatively affecting the quality of the stem cells. An important step towards successful stem cell transplants in patients for whom too few stem cells are available.

read more

Cryo-Save “Board of Parents” grand premiere

March 21, 2012 Group News

The Board of Parents program hosts its delegates at the flagship laboratory in Niel, Belgium

Cryo-Save is excited to deploy its program’s master piece to the participating parents and journalists attending the Board of Parents’ event on March 24th in Niel, Belgium. Volunteer parents have been recruited in eight European countries to take part in this program. The aim is to give the opportunity to Cryo-Save’s customers, to approach the company from a new perspective and to find out more on how a family stem cell bank works in terms of laboratory procedures and cryopreservation techniques.

read more

Page 1 of 212